The warrants were offered and sold at the rate of one warrant for every two shares of common stock purchased in the offering, with each full warrant having...
Sesen Bio Stockholders Expected to Receive Approximately $70 Million Special Cash Dividend, an Increase from up to $25 Million Previously Announced Cont...
Vaxart, Inc., a clinical-stage biotechnology company developing a range of oral recombinant vaccines based on its proprietary delivery platform, an...
© 2026 Biopharma Boardroom. All Rights Reserved.
